The complement system in systemic lupus erythematosus

References

• Miwa T, Song W-C. Membrane complement regulatory pro-teins: insight from animal studies and relevance to human disease. Int .1 Immunopharmacol 2001;1: 445–59.
   Google Scholar
• Holers VM. Complement as a regulatory and effector pathway in human disease. In: Lambris JD, Holers VM, eds. Therapeutic interventions in the complement system. Humana Press, 2000; pp. 1–32.
   Google Scholar
• Teixeira JE, Costa RS, Lachmann PJ, Wurzner R, Barbosa JE. CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patients. Clin Exp Immunol 1996;105: 497–503.
   Google Scholar
• Wang Y, Hu Q, Madri JA, Rollins SA, Chodera A, Matis LA. Amelioration of lupus-like autoimmune disease in NZB/W F1 mice after treatment with a monoclonal antibody specific for complement component C5. Proc Natl Acad Sci 1996;93:8563–8.
   PubMed Web of Science ®Google Scholar
• Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000;192:359–6.
   PubMed Web of Science ®Google Scholar
• Klickstein LB, Barbashov SF, Liu T, Jack RM, Nicholson-Weller A. Complement receptor 1 (CR1, CD35) is a receptor for Clq. Immunity 1997;7: 345–55.
   Google Scholar
• Nived O, Sturfelt G, Wollheim FA. Systemic lupus eryth-ematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med 1985;55:27 1–87.
   Google Scholar
• Garred P, Madsen HO, Halberg P, Petersen J, Kronberg G, Svejgaard A et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Artritis Rheum 1999;42:2145–52.
   PubMed Web of Science ®Google Scholar
• Sturfelt G, Sjöholm AG. Complement components, comple-ment activation and the acute phase response in systemic lupus erythematosus. Int Arch Allergy Immunol 1984;75:75–83.
   Google Scholar
• Sjöholm AG, Martensson U, Sturfelt G. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II and double stranded DNA in patients with systemic lupus erythematosus. J Rheumatol 1997;24:87 1–8.
   Google Scholar
• Martensson U, Sjöholm AG, Sturfelt G, Truedsson L, Laurell AB. Western blot analysis of human IgG reactive with the collagenous portion of Clq: evidence of distinct binding speci-ficities. Scand J Immunol 1992;35:735–44.
   Google Scholar
• Sturfelt G, Johnson U, Sjöholm AG. Sequential studies of complement activation in systemic lupus erythematosus. Scand J Rheumatol 1985;14:184–96.
   Google Scholar
• Buyon JP, Tamerius J, Belmont HB, Abramson SB. Assessment of disease activity and impending flares in patients with systemic lupus erythematosus. Comparison of comple- ment split products and conventional measurement of comple-ment. Arthritis Rheum 1992;9:102 8–37.
   Google Scholar
• Jonsson H, Sturfelt G, Mártensson U, Truedsson L, Sjöholm AG. Prospective analysis of Cl dissociation and complement activation in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1995;13:573–80.
   Google Scholar
• Manzi S, Rairie JE, Carpenter AB, Kelly RH, Jagarlapudi SP, Sereika SM et al. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity. Arthritis Rheum 1996;39:117 8–88.
   Google Scholar
• Mollnes TE, Haga HJ, Brun JG, Nielsen EW, Sjöholm AG, Sturfelt G et al. Complement activation in patients with systemic lupus erythematosus without nephritis. Rheumatology 1999;38:93 3–40.
   Google Scholar
• Sjöholm AG, Sturfelt G. Cleavage of C2 in pathological serum and plasma studied by crossed immunelectrophoresis. Acta pathol Microbiol Scand Sect C 1984;92: 265–9.
   Google Scholar
• Korb LC, Ahearn JMA. Clq binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 1997;158:452 5–8.
   Google Scholar
• Botto M, DellAgnola C, Bygrave AE, Thompson EM, Cook HT, Petry F et al. Homozygous Clq deficiency causes glom-erulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56–9.
   PubMed Web of Science ®Google Scholar
• Bengtsson A, Nezlin R, Shoenfeld Y, Sturfelt G. DNA levels in circulating immune complexes decrease at severe SLE flares - correlation with complement component Clq. J Autoimmun 1999;13:111–9.
   PubMedGoogle Scholar
• Carroll M. The role of complement and complement receptors in induction and regulation of immunity. Ann Rev Immunol 1998;16:545–68.
   PubMedGoogle Scholar
• Sturfelt G, Bengtsson A, Klint C, Nived O, Sjöholm AG, Truedsson L. Novel roles of complement in systemic lupus erythematosus - hypothesis for a pathogenetic vicious circle. J Rheumatol 2000;27:66 1–3.
   Google Scholar
• Entman ML, Rossen RD, Dreyer WJ, Anderson DC, Taylor AA, Smith CW. Inflammation in the course of early myocardial ischemia. FASEB J 1991;5:2529–37.
   PubMed Web of Science ®Google Scholar
• Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. Cl-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Phamacol Rev 2000;52:9 1–112.
   Google Scholar